Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
Outcomes for Older Adults with Depressive Symptoms: A Case Series Evaluating Metacognitive Training (MCT-Silver) in an Australian Community Sample
This study isn't recruiting yet.
In Australia
A Double-Blind, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Lucid-201 in Healthy Male and Female Volunteers and Patients with Depressive Symptoms on a selective-serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI)
This study isn't recruiting yet.
Multiple locations, including MelbourneA randomised, double-blind, active placebo-controlled, parallel groups dose-response study of intravenous scopolamine in major depressive disorder
This study has finished and is no longer accepting participants.
In New ZealandThis study has finished and is no longer accepting participants.
Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.
Multiple locations, including PhoenixA Multicentre, Open-Label, Phase 2 Safety Extension Study to Evaluate the Safety and Tolerability of R-107 in subjects with Refractory Major Depressive Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including SouthportA Pilot Study - Ziprasidone used as an Adjunctive Therapy in patients with Major Depressive Disorder: Impact on Symptoms and Functional Disability
This study ended early.
Location not clearly listedA randomised, double blind, active placebo-controlled crossover trial to evaluate the short term efficacy of an N-Methyl-D-Aspartate antagonist for patients with treatment resistant depression
This study has finished and is no longer accepting participants.
In New ZealandThis study evaluated the effectiveness of psychotherapy for people with depression.
This study has finished and is no longer accepting participants.
In AustraliaAgomelatine in Depression: An Exploratory Open Label Study of the Neurobiological Effects of Agomelatine in Adults with Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including WestmeadAn open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).
This study has finished and is no longer accepting participants.
In New ZealandA randomised controlled trial comparing Internet based cognitive behavioural therapy for major depressive disorder plus a cognitive bias modification intervention (OxIGen) vs. Internet based cognitive behavioural therapy for major depressive disorder vs. a waitlist control on symptoms of depression and negative interpretation bias.
This study has finished and is no longer accepting participants.
In Australia
Deep Brain Stimulation for the Treatment of Major Depressive Disorder
This study ended early.
In AustraliaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.